ofloxacin has been researched along with Dysmyelopoietic Syndromes in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmidt-Hieber, M | 1 |
Stroux, A | 1 |
Thiel, E | 1 |
Blau, IW | 1 |
Chou, SY | 1 |
Tsai, CC | 1 |
Kau, SC | 1 |
Kau, HC | 1 |
Hsu, WM | 1 |
Zaigraykin, N | 1 |
Kovalev, J | 1 |
Elias, N | 1 |
Naschitz, JE | 1 |
1 trial available for ofloxacin and Dysmyelopoietic Syndromes
Article | Year |
---|---|
Antibacterial prophylaxis with levofloxacin in patients after allogeneic stem cell transplantation and neutrophil reconstitution: results from a double-blinded, placebo-controlled phase III trial and overview of recent clinical practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Double-Blind Method; Female; Humans; Leukemia, Myelo | 2010 |
2 other studies available for ofloxacin and Dysmyelopoietic Syndromes
Article | Year |
---|---|
Aeromonas hydrophila orbital cellulitis in a patient with myelodysplastic syndrome.
Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cellulitis; Gr | 2004 |
Levofloxacin-induced interstitial nephritis and vasculitis in an elderly woman.
Topics: Acute Kidney Injury; Aged, 80 and over; Anti-Bacterial Agents; Fatal Outcome; Female; Humans; Levofl | 2006 |